可商量
发表于 2025-3-27 00:51:38
http://reply.papertrans.cn/67/6614/661367/661367_31.png
不满分子
发表于 2025-3-27 01:41:13
http://reply.papertrans.cn/67/6614/661367/661367_32.png
MILK
发表于 2025-3-27 08:07:56
Treatment of Nasal Polyposis with Biologics, specific biological. Future research should therefore focus on head-to-head comparisons of biologics and endotyping of responders and nonresponders to develop endotype-driven care pathways for CRSwNP.
乐意
发表于 2025-3-27 11:51:05
, Superantigens, and Nasal Polyps,tic therapy, contributing to the persistence of . and downstream inflammation. Epithelial barrier dysfunction results from altered expression of tight junction proteins in the nasal mucosa in the presence of ., and ultimately is a contributing factor to polyp formation. Therapeutic targets directed
breadth
发表于 2025-3-27 15:50:22
Categorization of Nasal Polyps, valuable means of monitoring an individual patient’s disease burden and their response to therapy..NP can be further categorized based on the predominant inflammatory cell population into eosinophilic, neutrophilic, and mixed types. Eosinophilia generally suggests a T helper type 2 (Th2) inflammati
一瞥
发表于 2025-3-27 18:51:43
http://reply.papertrans.cn/67/6614/661367/661367_36.png
Obedient
发表于 2025-3-28 01:59:18
http://reply.papertrans.cn/67/6614/661367/661367_37.png
milligram
发表于 2025-3-28 03:36:27
http://reply.papertrans.cn/67/6614/661367/661367_38.png
呼吸
发表于 2025-3-28 06:45:24
yposis in children, staphylococcus aureus, superantigens and nasal polyps, and antifungal treatment in chronic sinusitis. It offers comprehensive information to help readers improve the daily management of pati978-3-031-33201-2978-3-031-33199-2
Juvenile
发表于 2025-3-28 14:14:28
Harshita Pant,Rebecca Morrow,Damon Tumes,Raja Seethala